サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1363963

アフェレーシスの世界市場：2023-2030年

Global Apheresis Market 2023-2030

出版日
ページ情報
英文 105 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
アフェレーシスの世界市場：2023-2030年
出版日: 2023年09月22日
発行: Orion Market Research
ページ情報: 英文 105 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のアフェレーシス市場は、予測期間中（2023-2030年）にCAGR 8.4%で成長すると予測されています。市場の成長は、世界中で医療技術の革新が進んでいることに起因しています。Spectra Optiaのようなアフェレーシスシステムは、革新的で効果的な治療選択肢を提供し、世界的に使用量が増加しています。RBCXとして知られる治療法では、患者自身の赤血球（しばしば病気や欠陥のある細胞）が除去され、健康なドナーの赤血球と交換されます。鎌状赤血球貧血やその他のヘモグロビン異常症のような疾患の治療は、他の自己免疫疾患の治療に加えて、外科的処置を伴うことが多いです。そのため、市場各社は自動赤血球交換療法の需要に応える新製品を開発しています。例えば、2022年6月、英国のNHSイングランドは、鎌状赤血球症を治療するために、同社のSpectra Optia Apheresis Systemで実施される自動赤血球交換（RBCX）治療を選択しました。この選択により、Spectra Optiaは英国全土の病院に広く配備されることになっています。

セグメント別の展望

血小板療法サブセグメントが世界のアフェレーシス市場でかなりのシェアを占めると予想されます。

アプリケーションの中で、血小板療法サブセグメントが世界のアフェレーシス市場でかなりのシェアを占めると予想されています。このセグメントの成長は、世界中で慢性疾患の有病率が上昇していることに起因しています。自己免疫疾患、神経疾患、一部の悪性腫瘍など、さまざまな慢性疾患の治療にはアフェレーシス手術が行われることがあります。病気が流行するにつれ、アフェレーシス手術の需要は高まっています。米国国立衛生研究所（NIH）によると、2022年9月、血小板フェレーシスの検査を受けた7,478人のドナーのうち、3,232人（43.2％）に遅延があり、その内訳は男性3,089人（42.5％）、女性142人（63.1％）でした。延長の96.5％は一時的なものでした。低ヘモグロビン（Hb）（7.2％）と低静脈アクセス（それぞれ22.4％と47.4％）がその中に含まれています。低Hbのために辞退を受けたドナーの24.7％（234人中58人）は、Hbが12.0％から12.4％でした。現在のドナーの選択基準は、最低Hb12g/dl、最低血小板数140 103/lに開かれており、血小板療法の対象となるドナーの数を増やす可能性があります。

地域の展望

世界のアフェレーシス市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋（インド、中国、日本、韓国、その他アジア太平洋地域）、世界のその他の地域（中東とアフリカ、ラテンアメリカ）を含む地域別にさらにセグメント化されています。なかでもアジア太平洋地域は、高齢者人口の増加に伴い人口密度が高いことから、世界全体で大きなシェアを占めると予想されます。

北米地域はアフェレーシス世界市場において著しいCAGRで成長すると予想される

すべての地域の中で、北米地域は予測期間中にかなりのCAGRで成長すると予想されています。他のアフェレーシス技術サプライヤーに加え、自動採血と情報システムのメーカーが、彼らが供給する製品とサービスに対する需要の伸びを報告しています。米国国立衛生研究所（NIH）によると、2022年3月、固定施設は移動献血を中止した結果、アフェレーシス処置総数を37.0％増加させ、ベッド当たりの回転数を46.0％増加させましたが、ドナー1人当たりの採血量は減少しました。血小板失効率は6.8％（パンデミック前）から4.0％以下に低下しました。ドナーの関与度を測定するために使用されるドナー頻度は、2020年1月の1.6から2021年3月には1.8になっています。血液センターは、自動採血や情報システムなどの技術の進歩を活用することで、ドナーの関与を高め、流行期間中、単に特定の種類の血液製剤を過剰に蓄積することを回避しました。

目次

第1章 レポート概要

  • 業界の現状分析と成長可能性の展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Asahi Kasei Corp.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • B. Braun SE
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Baxter International, Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • 世界のアフェレーシス市場：製品別
    • アフェレーシス用消耗品
    • アフェレーシス用装置
  • 世界のアフェレーシス市場：処置別
    • 自動採血（ドナーアフェレーシス）
    • 治療用アフェレーシス
  • 世界のアフェレーシス市場：用途別
    • 血漿アフェレーシス
    • 血小板療法
    • 赤血球アフェレーシス
    • ロイカフェレーシス（白血球除去輸血）
    • フォトレーシス

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • 世界のその他の地域

第6章 企業プロファイル

  • Cerus Corp.
  • Crown Bioscience, Inc.
  • Fresenius SE & Co. KGaA
  • Haemonetics
  • Kaneka Corp.
  • Macopharma
  • Nikkiso Co., Ltd.
  • Otsuka Holdings Co., Ltd.
  • SB-KAWASUMI LABORATORIES, INC.
  • Terumo BCT
  • Toray Medical Co., Ltd.
図表

LIST OF TABLES

  • 1. GLOBAL APHERESIS MARKET RESEARCH AND ANALYSIS BYPRODUCT, 2022-2030 ($ MILLION)
  • 2. GLOBAL APHERESIS DISPOSABLES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL APHERESIS DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL APHERESIS CENTRIFUGAL DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL MEMBRANE SEPARATION DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL APHERESIS MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2022-2030 ($ MILLION)
  • 7. GLOBAL APHERESIS BASED ON AUTOMATED BLOOD COLLECTION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL APHERESIS BASED ON THERAPEUTIC MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL APHERESIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 10. GLOBAL APHERESIS IN PLASMAPHERESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL APHERESIS IN PLATELETPHERESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL APHERESIS IN ERYTHROCYTAPHERESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL APHERESIS IN LEUKAPHERESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL APHERESIS IN PHOTOPHERESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. GLOBAL APHERESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN APHERESIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN APHERESIS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN APHERESIS MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2022-2030 ($ MILLION)
  • 19. NORTH AMERICAN APHERESIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 20. EUROPEAN APHERESIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 21. EUROPEAN APHERESIS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 22. EUROPEAN APHERESIS MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2022-2030 ($ MILLION)
  • 23. EUROPEAN APHERESIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 24. ASIA-PACIFIC APHERESIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 25. ASIA-PACIFIC APHERESIS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 26. ASIA-PACIFIC APHERESIS MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2022-2030 ($ MILLION)
  • 27. ASIA-PACIFIC APHERESIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD APHERESIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD APHERESIS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD APHERESIS MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2022-2030 ($ MILLION)
  • 31. REST OF THE WORLD APHERESIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL APHERESIS MARKET SHARE BY PRODUCT, 2022 VS 2030 (%)
  • 2. GLOBAL APHERESIS DISPOSABLES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL APHERESIS DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL APHERESIS CENTRIFUGAL DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL APHERESIS MEMBRANE SEPARATION DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL APHERESIS MARKET SHARE BY PROCEDURE, 2022 VS 2030 (%)
  • 7. GLOBAL APHERESIS BASED ON AUTOMATED BLOOD COLLECTION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL APHERESIS BASED ON THERAPEUTIC APHERESIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL APHERESIS MARKET SHARE ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 10. GLOBAL APHERESIS IN PLASMAPHERESIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL APHERESIS IN PLATELETPHERESIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL APHERESIS IN ERYTHROCYTAPHERESIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL APHERESIS IN LEUKAPHERESIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL APHERESIS IN PHOTOPHERESIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL APHERESIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 16. US APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. CANADA APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. UK APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. FRANCE APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. GERMANY APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. ITALY APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. SPAIN APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. REST OF EUROPE APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. INDIA APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. CHINA APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. JAPAN APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. SOUTH KOREA APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. REST OF ASIA-PACIFIC APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD APHERESIS MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027669

Title: Global Apheresis Market Size, Share & Trends Analysis Report by Product (Apheresis Disposables, Apheresis Devices), by Procedure (Automated blood collection, Therapeutic Apheresis), and by Application (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis)Forecast Period (2023-2030).

The global apheresis market is anticipated to grow at a CAGR of 8.4% during the forecast period (2023-2030). The market's growth is attributed to the ongoing innovation in medical technology across the globe. Apheresis systems such as Spectra Optia provide innovative and effective treatment alternatives, increasing usage globally. In a therapeutic treatment known as RBCX, the patient's own red blood cells-often sick or defective cells-are removed and replaced with healthy donor red blood cells. Treatment for diseases like sickle cell anemia and other hemoglobinopathies, in addition to therapy for other autoimmune disorders, frequently involves surgical procedures. Accordingly, market players are coming up with new products to cater the demand for automated red blood cell exchange treatment. For instance, in June 2022, NHS England in the UK has chosen the automated red blood cell exchange (RBCX) treatment carried out on the company's Spectra Optia Apheresis System to treat sickle cell disease. This choice led to a wider deployment of Spectra Optia in hospitals throughout England.

Segmental Outlook

The global apheresis market is segmented on the product, procedure, and application. Based on the product, the market is sub-segmented into apheresis disposables, apheresis devices, centrifugal apheresis devices, and membrane separation devices. Based on the procedure, the market is sub-segmented into automated blood collection, therapeutic apheresis, therapeutic apheresis disposables, and therapeutic apheresis devices. Further, on the basis of application, the market is sub-segmented into plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis, and photopheresis. Among the application, the photospheres is sub-segment is anticipated to hold a considerable share of the market owing to the growing demand for photopheresis in organ transplant rejection therapies and increased prevalence of blood diseases.

The Plateletpheresis Sub-Segment is Anticipated to Hold a Considerable Share of the Global Apheresis Market

Among the application, the plateletpheresis sub-segment is expected to hold a considerable share of the global apheresis market. The segmental growth is attributed to the rising prevalence of chronic diseases around the globe. Treatment for a variety of chronic diseases, such as autoimmune disorders, neurological issues, and some malignancies, sometimes involves apheresis operations. Apheresis operations are in higher demand as the illnesses become more prevalent. According to the National Institute of Health (NIH), in September 2022, out of the 7,478 donors that were examined for plateletpheresis, 3,232 (43.2%) had delays, with 3,089 (42.5%) men and 142 (63.1%) women donors. 96.5% of extensions have been temporary. Low hemoglobin (Hb) (7.2%) and low venous access (22.4% and 47.4%, respectively, are among them. 24.7% (58 out of 234) of the donors that received a decline owing to the low Hb had a Hb between 12.0% and 12.4 %. The current donor selection criteria opened to a minimum Hb of 12 g/dl and minimum platelet count of 140 103/l, there is potential to increase the number of eligible plateletpheresis donors.

Regional Outlook

The global apheresis market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the high population density with an increase in senior citizen population.

The North America Region is Expected to Grow at a Significant CAGR in the Global Apheresis Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Manufacturers of automated blood collection and information systems in addition to other apheresis technology suppliers report growing demand for the products and services they supply. According to National Institute of Health (NIH), in March 2022, fixed sites increased total apheresis procedures by 37.0% and increased turns per bed by 46.0% as a result of the cancellation of mobile blood drives; however, less products were obtained per donor. Platelet expiration rate went from 6.8% (pre-pandemic) to less than 4.0% by simply obtaining the amount required. Donor frequency, that is used to measure donor involvement, went from 1.6 in January 2020 to 1.8 in March 2021. The blood center increased donor involvement and avoided accumulating an excess of simply specific kind of blood product throughout the epidemic by utilizing technology advancements such as automated blood collection and information systems.

Market Players Outlook

The major companies serving the global apheresis market include Cerus Corp., Crown Bioscience, Inc., Fresenius SE & Co. KGaA, Haemonetics, Kaneka Corp., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in August 2022, Terumo Blood and Cell Technologies, and Eliaz Therapeutics Inc. (ETI), collaborated to optimize the selective removal of an upstream inflammatory protein termed Galectin-3 (Gal-3) from blood plasma to help treat AKI and S-AKI.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global apheresis market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Asahi Kasei Corp.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. B. Braun SE
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Baxter International, Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Apheresis Market by Product
    • 4.1.1. Apheresis Disposables
    • 4.1.2. Apheresis Devices
  • 4.2. Global Apheresis Market by Procedure
    • 4.2.1. Automated Blood Collection (Donor Apheresis)
    • 4.2.2. Therapeutic Apheresis
  • 4.3. Global Apheresis Market by Application
    • 4.3.1. Plasmapheresis
    • 4.3.2. Plateletpheresis
    • 4.3.3. Erythrocytapheresis
    • 4.3.4. Leukapheresis
    • 4.3.5. Photopheresis

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Cerus Corp.
  • 6.2. Crown Bioscience, Inc.
  • 6.3. Fresenius SE & Co. KGaA
  • 6.4. Haemonetics
  • 6.5. Kaneka Corp.
  • 6.6. Macopharma
  • 6.7. Nikkiso Co., Ltd.
  • 6.8. Otsuka Holdings Co., Ltd.
  • 6.9. SB-KAWASUMI LABORATORIES, INC.
  • 6.10. Terumo BCT
  • 6.11. Toray Medical Co., Ltd.